Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Daniel J Rolfe

1PUBLICATIONS

7CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 20, 2024

Drug-resistant EGFR mutations promote lung cancer by stabilizing interfaces in ligand-free kinase-active EGFR oligomers.

R Sumanth Iyer, Sarah R Needham, Ioannis Galdadas

Pageof 1

Frequent Collaborators

1 joint publications

R Sumanth Iyer

1 joint publications

Sarah R Needham

1 joint publications

Laura C Zanetti-Domingues

1 joint publications

Gilbert O Fruhwirth

1 joint publications

Peter J Parker

1 joint publications

Francesco L Gervasio

1 joint publications

Marisa L Martin-Fernandez

Frequent Collaborators

1 joint publications

R Sumanth Iyer

1 joint publications

Sarah R Needham

1 joint publications

Laura C Zanetti-Domingues

1 joint publications

Gilbert O Fruhwirth

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos